Bhagwant Rai Mittal
Overview
Explore the profile of Bhagwant Rai Mittal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
469
Citations
1658
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Aggarwal P, Gunasekaran V, Sood A, Kumar N, Rathore Y, Kumar R, et al.
Clin Nucl Med
. 2025 Jan;
50(3):231-233.
PMID: 39773689
177 Lu-PSMA-617 radioligand therapy has been US Food and Drug Administration-approved safe and effective treatment modality for metastatic castration-resistant prostate cancer, usually administered in 4 to 6 cycles at 6...
12.
Aggarwal P, Gunasekaran V, Sood A, Mittal B
Best Pract Res Clin Endocrinol Metab
. 2025 Jan;
39(2):101967.
PMID: 39755470
Primary hyperparathyroidism is the main cause of hypercalcemia, resulting predominantly from parathyroid adenomas followed by hyperplasia. Diagnosis relies on clinical and biochemical parameters. Accurate pre-operative localization is mandatory for better...
13.
Preet K, Purohit P, Mittal B, Kumar R, Singh H, Shukla J, et al.
Clin Nucl Med
. 2024 Dec;
50(1):e57-e58.
PMID: 39626295
In recent years, 68Ga-FAP inhibitor has emerged as a possible substitute radiotracer to FDG for imaging of most of the tumors. Here, we report a 7-year-old girl diagnosed with recurrent...
14.
Chopra S, Walia R, Kaur K, Roesch F, Moon E, Mittal B, et al.
Clin Nucl Med
. 2024 Nov;
50(3):e160-e163.
PMID: 39501489
Metastatic or recurrent adrenocortical carcinoma is a potentially lethal malignancy, presenting significant challenges in disease management owing to absence of effective systemic treatments. Significantly diminished survival rates necessitate rapid identification...
15.
Aggarwal P, Gunasekaran V, Singh H, Kumar R, Satapathy S, Mittal B
Clin Nucl Med
. 2024 Oct;
50(1):e26-e33.
PMID: 39466639
Purpose: Early diagnosis and treatment of prostate cancer (PC) are crucial for effective management and improved patient outcomes. Newer imaging modalities like prostate-specific membrane antigen PET have shown superior diagnostic...
16.
Subedi U, Mahdi R, Mittal B, Singh H, Kumar R, Bachhal V
Clin Nucl Med
. 2024 Oct;
50(1):e62-e63.
PMID: 39388312
Primary osteosarcomas predominantly originate in the metaphyseal region of long bones. The introduction of 18 F-FDG PET/CT imaging has revealed unusual and often rare sites of metastatic spread. Peritoneal deposits...
17.
Aggarwal P, Gupta K, Sood A, Bora G, Goyal S, Singh H, et al.
Clin Nucl Med
. 2024 Sep;
49(11):e593-e594.
PMID: 39325517
Bilateral testicular involvement in prostate cancer is quite rare. It is often associated with widespread systemic disease and inadequate response to systemic therapy. We present a case of metastatic prostate...
18.
Kumar R, Krishnaraju V, Mittal B, Shankar K, Singh H, Ramachandran A, et al.
Nucl Med Mol Imaging
. 2024 Sep;
58(6):332-340.
PMID: 39308487
Purpose: PET/CT-based Deauville scoring (DS) is routinely used for lymphoma response assessment. However, pathological correlation of DS is not yet precisely documented. In the present study we aimed to pathological...
19.
Meena A, Mittal B, Singh H, Bora G, Kumar R
Indian J Nucl Med
. 2024 Sep;
39(3):220-221.
PMID: 39291078
Ga-68 labeled prostate-specific membrane antigen (PSMA) positron emission tomography-computed tomography (PET/CT) is increasingly recognized as the best imaging modality for disease staging and detection of recurrent prostate cancer. Despite its...
20.
Mahdi R, Krishnaraju V, Mittal B, Singh H, Kumar R, Prakash G
Indian J Nucl Med
. 2024 Sep;
39(3):224-226.
PMID: 39291059
Large vessel vasculitis is a known but rare side effect of granulocyte colony-stimulating factor (G-CSF) therapy. We report a case of adenocarcinoma lung with pleural infiltration and mediastinal lymphadenopathy, who...